DO PATIENTS WHO MEET CLASS IIA INDICATIONS FOR CARDIAC RESYNCHRONIZATION THERAPY ATTAIN A THERAPEUTIC BENEFIT?
Background Per the 2012 ACC guidelines, Cardiac Resynchronization Therapy (CRT) is a Class IIa recommendation for low EF patients with: 1) left bundle branch block (LBBB) pattern, QRS of 120-149 ms, and NYHA class II-IV symptoms and 2) non-LBBB pattern, QRS > 150 ms, and NYHA class III/IV symptom...
Gespeichert in:
| Veröffentlicht in: | Journal of the American College of Cardiology 2016-04, Vol.67 (13), p.1490-1490 |
|---|---|
| Hauptverfasser: | , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 1490 |
|---|---|
| container_issue | 13 |
| container_start_page | 1490 |
| container_title | Journal of the American College of Cardiology |
| container_volume | 67 |
| creator | Sinner, Gregory Gupta, Vedant Seratnahaei, Arash J Parrott, Kevin Charnigo, Richard Darrat, Yousef Elayi, Samy Leung, Steve Sorrell, Vincent |
| description | Background Per the 2012 ACC guidelines, Cardiac Resynchronization Therapy (CRT) is a Class IIa recommendation for low EF patients with: 1) left bundle branch block (LBBB) pattern, QRS of 120-149 ms, and NYHA class II-IV symptoms and 2) non-LBBB pattern, QRS > 150 ms, and NYHA class III/IV symptoms, however the clinical benefit in this group is unclear. |
| doi_str_mv | 10.1016/S0735-1097(16)31491-7 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_journals_1780640465</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0735109716314917</els_id><sourcerecordid>4020609181</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2327-b6aa118ff259358a624f7e22858eaa367ade58bb8d68f0ddee3055c24dadedeb3</originalsourceid><addsrcrecordid>eNqFkF9r2zAUxcVYYVm3jzAQ9GV98CZZ1h-_NKiO0ghSu9gqo3sRii2DsyxOrXbQb18nKSv0pU_i6pz7u_ceAL5h9AMjzH5WiBMaYZTy75idE5ykOOIfwARTKiJCU_4RTP5bPoHPIawRQkzgdAK2swLeSKNVbir4a1HAa6UMzJayqqDWEup8prNRL_IKzosSZrKcaZnBUlV3ebYoi1z_PsjQLFQpb-6gNEbqHMqXD3VrdAYvVa7m2ky_gJPWbYL_-vKegtu5MtkiWhZX45xlVMck5tGKOYexaNuYpoQKx-Kk5T6OBRXeOcK4azwVq5VomGhR03hPEKV1nDSj0PgVOQVnR-5u6O8ffXiw6_5x2I4jLeYCsQQljI4uenTVQx_C4Fu7G7q_bniyGNl9tPYQrd3nZsfqEK3lY9_02OfHE_51frCh7vy29k03-PrBNn33LuHiDaHedNuudps__smH12VtiC06QvYMzA4ETp4Bt-SL-g</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1780640465</pqid></control><display><type>article</type><title>DO PATIENTS WHO MEET CLASS IIA INDICATIONS FOR CARDIAC RESYNCHRONIZATION THERAPY ATTAIN A THERAPEUTIC BENEFIT?</title><source>Access via ScienceDirect (Elsevier)</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Sinner, Gregory ; Gupta, Vedant ; Seratnahaei, Arash J ; Parrott, Kevin ; Charnigo, Richard ; Darrat, Yousef ; Elayi, Samy ; Leung, Steve ; Sorrell, Vincent</creator><creatorcontrib>Sinner, Gregory ; Gupta, Vedant ; Seratnahaei, Arash J ; Parrott, Kevin ; Charnigo, Richard ; Darrat, Yousef ; Elayi, Samy ; Leung, Steve ; Sorrell, Vincent</creatorcontrib><description>Background Per the 2012 ACC guidelines, Cardiac Resynchronization Therapy (CRT) is a Class IIa recommendation for low EF patients with: 1) left bundle branch block (LBBB) pattern, QRS of 120-149 ms, and NYHA class II-IV symptoms and 2) non-LBBB pattern, QRS > 150 ms, and NYHA class III/IV symptoms, however the clinical benefit in this group is unclear.</description><identifier>ISSN: 0735-1097</identifier><identifier>EISSN: 1558-3597</identifier><identifier>DOI: 10.1016/S0735-1097(16)31491-7</identifier><language>eng</language><publisher>New York: Elsevier Inc</publisher><subject>Cardiology ; Cardiovascular ; Electrocardiography ; Heart attacks ; Internal Medicine</subject><ispartof>Journal of the American College of Cardiology, 2016-04, Vol.67 (13), p.1490-1490</ispartof><rights>American College of Cardiology Foundation</rights><rights>2016 American College of Cardiology Foundation</rights><rights>Copyright Elsevier Limited Apr 5, 2016</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/S0735-1097(16)31491-7$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>315,781,785,3551,27925,27926,45996</link.rule.ids></links><search><creatorcontrib>Sinner, Gregory</creatorcontrib><creatorcontrib>Gupta, Vedant</creatorcontrib><creatorcontrib>Seratnahaei, Arash J</creatorcontrib><creatorcontrib>Parrott, Kevin</creatorcontrib><creatorcontrib>Charnigo, Richard</creatorcontrib><creatorcontrib>Darrat, Yousef</creatorcontrib><creatorcontrib>Elayi, Samy</creatorcontrib><creatorcontrib>Leung, Steve</creatorcontrib><creatorcontrib>Sorrell, Vincent</creatorcontrib><title>DO PATIENTS WHO MEET CLASS IIA INDICATIONS FOR CARDIAC RESYNCHRONIZATION THERAPY ATTAIN A THERAPEUTIC BENEFIT?</title><title>Journal of the American College of Cardiology</title><description>Background Per the 2012 ACC guidelines, Cardiac Resynchronization Therapy (CRT) is a Class IIa recommendation for low EF patients with: 1) left bundle branch block (LBBB) pattern, QRS of 120-149 ms, and NYHA class II-IV symptoms and 2) non-LBBB pattern, QRS > 150 ms, and NYHA class III/IV symptoms, however the clinical benefit in this group is unclear.</description><subject>Cardiology</subject><subject>Cardiovascular</subject><subject>Electrocardiography</subject><subject>Heart attacks</subject><subject>Internal Medicine</subject><issn>0735-1097</issn><issn>1558-3597</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2016</creationdate><recordtype>article</recordtype><recordid>eNqFkF9r2zAUxcVYYVm3jzAQ9GV98CZZ1h-_NKiO0ghSu9gqo3sRii2DsyxOrXbQb18nKSv0pU_i6pz7u_ceAL5h9AMjzH5WiBMaYZTy75idE5ykOOIfwARTKiJCU_4RTP5bPoHPIawRQkzgdAK2swLeSKNVbir4a1HAa6UMzJayqqDWEup8prNRL_IKzosSZrKcaZnBUlV3ebYoi1z_PsjQLFQpb-6gNEbqHMqXD3VrdAYvVa7m2ky_gJPWbYL_-vKegtu5MtkiWhZX45xlVMck5tGKOYexaNuYpoQKx-Kk5T6OBRXeOcK4azwVq5VomGhR03hPEKV1nDSj0PgVOQVnR-5u6O8ffXiw6_5x2I4jLeYCsQQljI4uenTVQx_C4Fu7G7q_bniyGNl9tPYQrd3nZsfqEK3lY9_02OfHE_51frCh7vy29k03-PrBNn33LuHiDaHedNuudps__smH12VtiC06QvYMzA4ETp4Bt-SL-g</recordid><startdate>20160405</startdate><enddate>20160405</enddate><creator>Sinner, Gregory</creator><creator>Gupta, Vedant</creator><creator>Seratnahaei, Arash J</creator><creator>Parrott, Kevin</creator><creator>Charnigo, Richard</creator><creator>Darrat, Yousef</creator><creator>Elayi, Samy</creator><creator>Leung, Steve</creator><creator>Sorrell, Vincent</creator><general>Elsevier Inc</general><general>Elsevier Limited</general><scope>6I.</scope><scope>AAFTH</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>7TK</scope><scope>H94</scope><scope>K9.</scope><scope>NAPCQ</scope></search><sort><creationdate>20160405</creationdate><title>DO PATIENTS WHO MEET CLASS IIA INDICATIONS FOR CARDIAC RESYNCHRONIZATION THERAPY ATTAIN A THERAPEUTIC BENEFIT?</title><author>Sinner, Gregory ; Gupta, Vedant ; Seratnahaei, Arash J ; Parrott, Kevin ; Charnigo, Richard ; Darrat, Yousef ; Elayi, Samy ; Leung, Steve ; Sorrell, Vincent</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2327-b6aa118ff259358a624f7e22858eaa367ade58bb8d68f0ddee3055c24dadedeb3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2016</creationdate><topic>Cardiology</topic><topic>Cardiovascular</topic><topic>Electrocardiography</topic><topic>Heart attacks</topic><topic>Internal Medicine</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sinner, Gregory</creatorcontrib><creatorcontrib>Gupta, Vedant</creatorcontrib><creatorcontrib>Seratnahaei, Arash J</creatorcontrib><creatorcontrib>Parrott, Kevin</creatorcontrib><creatorcontrib>Charnigo, Richard</creatorcontrib><creatorcontrib>Darrat, Yousef</creatorcontrib><creatorcontrib>Elayi, Samy</creatorcontrib><creatorcontrib>Leung, Steve</creatorcontrib><creatorcontrib>Sorrell, Vincent</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Premium</collection><jtitle>Journal of the American College of Cardiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sinner, Gregory</au><au>Gupta, Vedant</au><au>Seratnahaei, Arash J</au><au>Parrott, Kevin</au><au>Charnigo, Richard</au><au>Darrat, Yousef</au><au>Elayi, Samy</au><au>Leung, Steve</au><au>Sorrell, Vincent</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>DO PATIENTS WHO MEET CLASS IIA INDICATIONS FOR CARDIAC RESYNCHRONIZATION THERAPY ATTAIN A THERAPEUTIC BENEFIT?</atitle><jtitle>Journal of the American College of Cardiology</jtitle><date>2016-04-05</date><risdate>2016</risdate><volume>67</volume><issue>13</issue><spage>1490</spage><epage>1490</epage><pages>1490-1490</pages><issn>0735-1097</issn><eissn>1558-3597</eissn><abstract>Background Per the 2012 ACC guidelines, Cardiac Resynchronization Therapy (CRT) is a Class IIa recommendation for low EF patients with: 1) left bundle branch block (LBBB) pattern, QRS of 120-149 ms, and NYHA class II-IV symptoms and 2) non-LBBB pattern, QRS > 150 ms, and NYHA class III/IV symptoms, however the clinical benefit in this group is unclear.</abstract><cop>New York</cop><pub>Elsevier Inc</pub><doi>10.1016/S0735-1097(16)31491-7</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0735-1097 |
| ispartof | Journal of the American College of Cardiology, 2016-04, Vol.67 (13), p.1490-1490 |
| issn | 0735-1097 1558-3597 |
| language | eng |
| recordid | cdi_proquest_journals_1780640465 |
| source | Access via ScienceDirect (Elsevier); EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection |
| subjects | Cardiology Cardiovascular Electrocardiography Heart attacks Internal Medicine |
| title | DO PATIENTS WHO MEET CLASS IIA INDICATIONS FOR CARDIAC RESYNCHRONIZATION THERAPY ATTAIN A THERAPEUTIC BENEFIT? |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-18T13%3A28%3A06IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=DO%20PATIENTS%20WHO%20MEET%20CLASS%20IIA%20INDICATIONS%20FOR%20CARDIAC%20RESYNCHRONIZATION%20THERAPY%20ATTAIN%20A%20THERAPEUTIC%20BENEFIT?&rft.jtitle=Journal%20of%20the%20American%20College%20of%20Cardiology&rft.au=Sinner,%20Gregory&rft.date=2016-04-05&rft.volume=67&rft.issue=13&rft.spage=1490&rft.epage=1490&rft.pages=1490-1490&rft.issn=0735-1097&rft.eissn=1558-3597&rft_id=info:doi/10.1016/S0735-1097(16)31491-7&rft_dat=%3Cproquest_cross%3E4020609181%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1780640465&rft_id=info:pmid/&rft_els_id=S0735109716314917&rfr_iscdi=true |